Medicament for targeted therapy of ovarian cancer and preparation method of medicament

A targeted therapy, ovarian cancer technology, applied in the field of medicine, to achieve the effect of controlling the proliferation and metastasis of cancer cells and promoting lysis

Inactive Publication Date: 2018-01-09
湖南晓林生物科技发展有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Further research in the later period showed that compound aluminum sulfate injection has a certain therapeutic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for targeted therapy of ovarian cancer and preparation method of medicament
  • Medicament for targeted therapy of ovarian cancer and preparation method of medicament
  • Medicament for targeted therapy of ovarian cancer and preparation method of medicament

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for targeted therapy of ovarian cancer and a preparation method of the medicament. Research made for a long time shows that aluminum sulfate has the effects of distinguishing and recognizing normal tissues and cancer tissues of human bodies, changing the physiological characteristics of cancer cells, inhibiting the cancer cells from secreting various kinds of proteinase and inhibiting the metabolic function of mitochondria of the cancer cells, thereby realizing an anti-tumor effect, can be bound into DNAs (deoxyribonucleic acids) of the cancer cells to promote cleavage of the DNAs, rapidly strongly converge and coagulate glycoproteins on the surfaces of the cells, effectively change protein structures on the surfaces of the cells, block signal paths andchange cell microstructures, is bound with succinate dehydrogenase in the mitochondria of the cells to effectively control proliferation and transfer of the cancer cells, the inhibition rate of the cancer cells reaches 99.8 to 99.9 percent and even 100 percent. The aluminum sulfate has less side effects, high safety and great practical significance on conquering ovarian cancer by human beings, and also has the advantages of microdose, fast efficacy, short treatment course and the like for targeted therapy of ovarian cancer, and tumor bodies can be rapidly reduced, induced to apoptasis, inhibited from proliferating and finally fragmented and exfoliated.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicine for treating ovarian cancer and a preparation method thereof. Background technique [0002] As we all know, malignant tumor is a kind of frequently-occurring and common disease that seriously threatens human health. Together with viral diseases and senile diseases, it is called the three major challenges of modern medicine. Its pathogenesis has not been fully elucidated, and the treatment effect is not satisfactory. According to incomplete statistics, the global average annual expenditure on cancer research and development and treatment is not less than tens of billions, which brings huge losses to the country, society and individuals. [0003] Ovarian cancer is a malignant tumor of the ovary, which refers to malignant tumors growing on the ovary, of which 90% to 95% are primary ovarian cancers, and the other 5% to 10% are primary cancers that have metastasized to other parts. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K33/06A61P35/00
Inventor 谢丹
Owner 湖南晓林生物科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products